In breast cancers, oncogenic mutations in the gene encoding the p110α catalytic subunit (PIK3CA) and deletion or truncation of the gene encoding PTEN are present in up to 45 and 40% of human breast tumours respectively, generally in a mutually exclusive manner (18). Here, PTEN is linked to breast carcinoma.